Researchers identify changes in lung cells following infections

May 17, 2017, Boston University Medical Center

When people develop a respiratory infection, recovery from their illness leaves behind an immunological memory that influences how they will respond to later infections.

In a new study, researchers demonstrate for the first time that recovery from bacterial pneumonia changes the tissue that was infected, seeding the lungs with immune cells called resident memory T (TRM) cells.

Differences in the numbers and activities of these lung TRM cells may be responsible for the increased susceptibility of young and to pneumonia and manipulating these cells may provide novel treatment options for curing pneumonia. The study appears in the journal Mucosal Immunology.

Worldwide, pneumonia remains a serious public health burden. Each year more than one million children under the age of five die from pneumonia and associated complications. In the U.S., pneumonia is the most common reason for the hospitalization of children and accounts for nearly half of the infectious disease-related hospitalizations and deaths of older .

To model the typical experience of most children, an experimental model received a series of mild and non-life threatening respiratory infections. A control model received sterile saline instead of infections. When compared to the control model, those with prior respiratory infections were profoundly resistant to severe (life-threatening) pneumonia.

"Our study suggests that respiratory bacterial infections during childhood establish a novel type of antibacterial immunity," explained corresponding author Joseph Mizgerd, ScD, professor of medicine, microbiology and biochemistry at Boston University School of Medicine. "The TRM cells left behind after prior infections are more broadly effective than vaccine-generated immunity, providing protection against a wider spectrum of microbes that can infect the lungs."

Young children and older adults are highly susceptible to pneumonia, but the factors that are responsible for preventing pneumonia in young healthy adults are still not understood. "We have only modest abilities to prevent or cure many of the infections that cause . Defining the protective mechanisms normally preventing in most young healthy adults will lead to tests identifying who is susceptible and new approaches for preventing and treating the infections," added Mizgerd.

Explore further: Inhaled corticosteroids not linked to pneumonia in children

More information: N MS Smith et al, Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia, Mucosal Immunology (2017). DOI: 10.1038/MI.2017.43

Related Stories

Inhaled corticosteroids not linked to pneumonia in children

February 27, 2017
(HealthDay)—Inhaled corticosteroids (ICS) do not appear to be associated with the risk of pneumonia in children with asthma, according to a review published online Feb. 24 in Pediatrics.

Prevnar, Pfizer's pneumonia vaccine, okayed for adults in EU

March 3, 2015
Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older.

Team uses Google analytical tool to gauge vaccine effectiveness

February 1, 2017
Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published in the Proceedings of ...

Flu shot may curb respiratory infections in people with heart failure

February 2, 2017
(HealthDay)—Flu and pneumonia vaccines may reduce heart failure patients' risk of dangerous respiratory infections, a new review suggests.

High monthly vitamin D reduces respiratory infections, may increase falls for older adults

January 5, 2017
In people over the age of 65, acute respiratory infections—such as the common cold, influenza, or pneumonia—can lead to potentially life-threatening complications.

RSV infection may be associated with higher risk for bacterial pneumonia

January 6, 2015
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's ...

Recommended for you

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...

Immune system 'double agent' could be new ally in cancer fight

March 16, 2018
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...

Artificial sweetener Splenda could intensify symptoms in those with Crohn's disease

March 15, 2018
In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener ...

Researchers identify common biological features of different types of asthma

March 14, 2018
A team of researchers from the NIHR Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung ...

Scientists discover treatment target for sepsis

March 14, 2018
In a study published in Nature Communications, Northwestern Medicine scientists demonstrated the key role a molecule called oxPAPC plays in regulating the inflammatory response—findings which could inform the development ...

Researcher creates 'Instagram' of immune system, blending science, technology

March 10, 2018
Being on the cutting edge of science and technology excites Hollings Cancer Center (HCC) researcher Carsten Krieg, Ph.D. Each day, he walks into his lab that houses a mass cytometry machine aptly labeled Helios. Krieg explains ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.